Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DDI2 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
mRNA | BCAS4 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
mRNA | TNF | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
mRNA | MSH4 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
mRNA | CCL4 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
mRNA | CASKIN2 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
mRNA | RBFOX2 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
mRNA | CD33 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
mRNA | F13A1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
mRNA | IL3RA | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |